NCT06471478View on ClinicalTrials.gov

The Combination of IVIG, Dexamethasone and a Megadose of PBSCs for Decreasing DSAs

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

October 30, 2021

Study Completion Date

August 30, 2023

Conditions
Blood Disease
Interventions
COMBINATION_PRODUCT

intravenous immunoglobulin, dexamethasone and a megadose of peripheral-blood stem cell transfusion

patients received intravenous immunoglobulin, dexamethasone and a megadose of peripheral-blood stem cell transfusion for decresing donor specific antibodies.

Trial Locations (1)

650000

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China, Kunming

All Listed Sponsors
lead

Hematology department of the 920th hospital

OTHER

NCT06471478 - The Combination of IVIG, Dexamethasone and a Megadose of PBSCs for Decreasing DSAs | Biotech Hunter | Biotech Hunter